Senti Biosciences, Inc.SNTINASDAQ
LOADING
|||
| Metric | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 |
|---|---|---|---|---|---|
| Revenue Growth | -100.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Gross Profit Growth | -100.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EBITDA Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Net Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Diluted Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Weighted Average Shares Growth | +2.92% | +2.04% | +0.55% | +470.46% | +473.03% |
| Weighted Average Shares Diluted Growth | +2.92% | +2.04% | +0.55% | +470.46% | +473.03% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Free Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Receivables Growth | -99.60% | -89.80% | -87.62% | -80.22% | +98.65% |
| Inventory Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Asset Growth | -56.19% | -18.11% | -18.99% | -21.14% | -8.72% |
| Book Value per Share Growth | -81.26% | -62.43% | -32.88% | -90.21% | -91.14% |
| Debt Growth | -6.98% | -10.69% | -11.65% | -12.39% | -13.22% |
| R&D Expense Growth | -4.81% | -17.34% | +8.94% | +10.22% | +18.88% |
| SG&A Expenses Growth | -25.96% | -8.47% | +1.49% | +126.16% | -7.88% |